Brenton L. Saunders
Director at Cambrian BioPharma.
Raised on Cambrian BioPharma filings
$123.8M
of $129.8M offered across 1 Form D filing
- Form D filings
- 1
- Teammates
- 10
- Last filing
- Jul 15, 2026
Company
Drugs that target the biology of aging
- Investors
- 80
- Still open
- $6M
Cambrian BioPharma filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Jul 15, 2026 | Equity | $123.8M/ $129.8M | Form D |
- EquityFiled Jul 15, 2026Form D$123.8M/ $129.8M
Works with
William DeVaulChief Legal Officer, Form D signerForm D signerLorin Van NulandDirectorJames PeyerExecutive Officer, DirectorJuliette HanExecutive Officer, DirectorRuth Thieroff-EkerdtExecutive OfficerChristian AngermeyerDirectorMark NuttallExecutive OfficerMartin GunhagaDirectorMaryanna SaenkoDirectorPaul FarrDirector
